UCGI

United Cancer Group (UCG) is a biotechnology company focused on the development of precision oncology solutions and advanced cancer diagnostics. The company integrates genomic profiling with therapeutic development to create personalized treatment pathways for patients with various solid tumors. UCG's business model encompasses both the discovery of novel biomarkers and the advancement of targeted therapies designed to address specific genetic mutations. By leveraging its proprietary diagnostic platform, the company aims to improve clinical outcomes through more accurate patient stratification and monitoring. United Cancer Group operates with a mission to bridge the gap between complex genomic data and actionable clinical interventions in the oncology space.